News Ipsen announces CheckMate 3-yr follow-up aRCC results Ipsen has announced the three-year follow up results from its CheckMate -9ER study
News Roche adds another obesity drug with $1.16bn Rona deal Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ALK7.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
